Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Open-label”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04083716
What this trial is testing

Assess the Relative Bioavailability and Food Effect of ABI-H2158 in Healthy Adults

Who this might be right for
Chronic Hepatitis B
Assembly Biosciences 15
Early research (Phase 1)Study completedNCT00768404
What this trial is testing

Evaluate the Pharmacokinetics of VI-0521 Subjects With Renal Impairment

Who this might be right for
Renal Impairment
VIVUS LLC 32
Testing effectiveness (Phase 2)Study completedNCT01222533
What this trial is testing

Tiotropium Respimat Pharmacokinetic Study in COPD

Who this might be right for
Pulmonary Disease, Chronic Obstructive
Boehringer Ingelheim 154
Testing effectiveness (Phase 2)Ended earlyNCT01573247
What this trial is testing

Safety Study of AKN-028 in Patients With Acute Myelogenous Leukemia

Who this might be right for
Acute Myeloid Leukemia
Akinion Pharmaceuticals AB 25
Not applicableStudy completedNCT00771147
What this trial is testing

A Trial to Evaluate the Characteristics of Patients Treated for Advanced Renal Cell Carcinoma With Nexavar ®

Who this might be right for
Carcinoma, Renal CellCarcinoma, Renal Cell (Advanced)
Bayer 71
Testing effectiveness (Phase 2)Ended earlyNCT02976038
What this trial is testing

Open-Label Extension Trial to Characterize the Long-term Safety and Tolerability of Elamipretide in Subjects With Genetically Confirmed Primary Mitochondrial Myopathy (PMM)

Who this might be right for
Primary Mitochondrial Disease
Stealth BioTherapeutics Inc. 28
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07339748
What this trial is testing

A Clinical Study of ZL-85FA Tablets

Who this might be right for
Advanced Solid Tumor
Chengdu Zenitar Biomedical Technology Co., Ltd 51
Early research (Phase 1)Not Yet RecruitingNCT06661148
What this trial is testing

Study of EPI-003 in Select Nucleos(t)Ide Analogue-Treated, Chronic Hepatitis B Patients

Who this might be right for
Chronic Hepatitis BHBV (Hepatitis B Virus)
Epigenic Therapeutics, Inc 36
Large-scale testing (Phase 3)Study completedNCT02953548
What this trial is testing

Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms (GWPCARE7)

Who this might be right for
Infantile Spasms
Jazz Pharmaceuticals 9
Large-scale testing (Phase 3)Study completedNCT00396526
What this trial is testing

ICMR-Indiaclen Trial on Amoxycillin vs Cotrimoxazole for Non-Severe Pneumonia

Who this might be right for
Non-Severe PneumoniaUnder-FivesChildren
King George's Medical University 2,000
Early research (Phase 1)Study completedNCT07226778
What this trial is testing

Comparing the Extent to Which Maridebart Cafraglutide (AMG 133) is Made Available in the Body When Administered Using Two Subcutaneous (SC) Presentations

Who this might be right for
OverweightObesity
Amgen 348
Early research (Phase 1)UnknownNCT04085185
What this trial is testing

A Study Evaluating the Safety, Tolerability, and Initial Efficacy of IBI110 in Subjects With Advanced Malignant Tumors

Who this might be right for
Advanced Malignancies
Innovent Biologics (Suzhou) Co. Ltd. 268
Early research (Phase 1)Active Not RecruitingNCT03401385
What this trial is testing

First-in-human Study of DS-1062a for Advanced Solid Tumors (TROPION-PanTumor01)

Who this might be right for
Hormone Receptor Positive Breast CancerTriple Negative Breast CancerNon-small Cell Lung Cancer
Daiichi Sankyo Co., Ltd. 890
Testing effectiveness (Phase 2)Study completedNCT01634243
What this trial is testing

A Dose-ranging Study for SPM 962 in Parkinson's Disease Patients

Who this might be right for
Parkinson's Disease
Otsuka Pharmaceutical Co., Ltd. 64
Testing effectiveness (Phase 2)Ended earlyNCT01602315
What this trial is testing

A Phase Ib/II Study of BYL719 and Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Recurrent Head and Neck Squamous Cell CarcinomaMetastatic Head and Neck Squamous Cell Carcinoma
Novartis Pharmaceuticals 179
Not applicableLooking for participantsNCT07145489
What this trial is testing

Infrared Photobiomodulation in Humans With Epilepsy

Who this might be right for
Drug Resistant Epilepsy
Beth Israel Deaconess Medical Center 13
Post-approval studies (Phase 4)Study completedNCT01119768
What this trial is testing

Esomeprazole Treatment Co-diagnosed Non Erosive Reflux Disease (NERD) and Chronic Gastritis Patients

Who this might be right for
Non Erosive Reflux DiseaseChronic Gastritis
AstraZeneca 305
Testing effectiveness (Phase 2)Ended earlyNCT01133990
What this trial is testing

FOLFIRI Alone Versus FOLFIRI Plus Bevacizumab Versus FOLFIRI Plus E7820 as Second-Line Therapy in Patients With Locally Advanced or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Eisai Inc. 5
Testing effectiveness (Phase 2)Study completedNCT02698410
What this trial is testing

Efficacy and Safety of Lanreotide Autogel (ATG) in Combination With Temozolomide in Subjects With Thoracic Neuroendocrine Tumors.

Who this might be right for
Neuroendocrine Tumours
Ipsen 40
Early research (Phase 1)Study completedNCT06679413
What this trial is testing

Assess Drug-drug Interaction of ZX008 in Healthy Male and Female Study Participants

Who this might be right for
Healthy Study Participants
UCB BIOSCIENCES, Inc. 22
Next Page